Below is a daily summary of links to the latest SPAC news and rumors gathered across the web.
Latest SPAC News: VAM SPAC to take Supermoney public, SPAC listings gain momentum in Korea, and Starton Therapeutics receives authorization from FDA
Former Bulgari chief’s SPAC agrees deal for comparison site Supermoney
Supermoney and Dutch special purpose acquisition company VAM SPAC have signed a binding accord aimed at taking the online price comparison provider public, the companies said on Monday.
Shareholders of Supermoney, which offers price comparison and technology services mainly in the energy, gas and telecoms sectors, will buy a majority stake in VAM SPAC, which in turn will take 100% of the broker’s capital.
READLarge SPAC listings gain momentum in Korea
The Korean SPAC market with typical offerings of around 10 billion won ($800,000) is now witnessing consecutive listings of large-scale SPACs with over 30 billion won.
According to sources on Monday, KB Securities Co. is conducting book building for KB SPAC No. 24, which has a public offering size of around 32 billion won.
Starton Therapeutics Receives Authorization from the FDA to Proceed with STAR-LLD Lenalidomide Phase 1b Clinical Trial in Multiple Myeloma
Starton Therapeutics Inc., a clinical stage biotechnology company focused on transforming standard-of-care therapies with proprietary continuous delivery technology, today provided updates on its Phase 1b STAR-LLD clinical trial of its investigational continuous delivery lenalidomide in multiple myeloma.
Starton has signed an agreement for a business combination with Healthwell Acquisition Corp. I (Nasdaq: HWEL).
READ
An In-Depth Look at SPAC Activity Throughout the Third Quarter of 2023 Below is a summary of the year-to-date SPAC performance. We’re now three-quarters of the way through 2023 and while activity remains muted, there is a sense that SPACs have run the most difficult part of the “correction” gauntlet and have reached a better...
Terms Tracker for the Week Ending September 29, 2023 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week’s pricings. As September comes to a close, SPACs did not price any IPOs during the month with the most recent IPO (99 Acquisition Group) having priced...
Athena Consumer Acquisition Corp. (NYSE:ACAQ) announced this afternoon that its stockholders approved its combination with German EV-maker e.GO at a special meeting held earlier today. Additionally, Athena Consumer’s warrant proposal to convert all outstanding warrants to 0.175 shares in the combined company was also approved. A total of 884,880 shares of Athena Class A Common...
October is set to be a quiet month for lock-up expirations with only four de-SPACs and four sponsors now open to trade their shares for the first time. The first customer is Bitdeer Technologies. Its shareholders and the Blue Safari sponsor both stand to gain the most out of this group from moving some of...
Graf Acquisition Corp. IV (NYSE:GFOR) announced in an 8-K this afternoon that its shareholders approved its combination with NKGen Biotech at a special meeting September 25. A total of 3,386,528 shares were redeemed in connection with the vote, leaving Graf IV with about $27.6 million in the tank and a final redemption rate of 84.3%....